Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
139.75 EUR | -0.14% | -1.31% | -3.02% |
12-03 | MERCK KGAA : Receives a Buy rating from JP Morgan | ZD |
12-02 | MERCK KGAA : Receives a Buy rating from DZ Bank | ZD |
Chart calendar Merck KGaA
Upcoming events on Merck KGaA
Past events on Merck KGaA
14/11/2024 13:00 | Q3 2024 Earnings Call |
14/11/2024 06:00 | Q3 2024 Earnings Release |
22/10/2024 04:15 | BioProcess International Asia |
17/10/2024 08:45 | Capital Markets Day |
01/08/2024 13:00 | Q2 2024 Earnings Call |
01/08/2024 06:00 | Q2 2024 Earnings Release |
03/06/2024 19:30 | American Society of Clinical Oncology Meeting - Abstract No - 8575 |
03/06/2024 16:12 | American Society of Clinical Oncology Meeting - Abstract No - 4508 |
03/06/2024 15:00 | American Society of Clinical Oncology Meeting - Abstract No - 3018 |
03/06/2024 14:00 | R&D Day |
02/06/2024 15:00 | American Society of Clinical Oncology Meeting - Abstract No - 4567 |
02/06/2024 15:00 | American Society of Clinical Oncology Meeting - Abstract No - 4566 |
02/06/2024 15:00 | American Society of Clinical Oncology Meeting - Abstract No - TPS6126 |
01/06/2024 19:30 | American Society of Clinical Oncology Meeting - Abstract No - LBA3559 |
01/06/2024 19:30 | American Society of Clinical Oncology Meeting - Abstract No - 3550 |
01/06/2024 15:00 | American Society of Clinical Oncology Meeting - Abstract No - 2614 |
01/06/2024 15:00 | American Society of Clinical Oncology Meeting - Abstract No - 2612 |
01/06/2024 09:00 | American Society of Clinical Oncology Meeting - Abstract No - 3000 |
30/05/2024 | American Society of Clinical Oncology Meeting - Abstract No - e18039 |
15/05/2024 13:00 | Q1 2024 Earnings Call |
Past dividends on Merck KGaA
28/04/2024 | Annual 2.2 EUR |
01/05/2023 | Annual 2.2 EUR |
24/04/2022 | Annual 1.85 EUR |
25/04/2021 | Annual 1.4 EUR |
28/05/2020 | Annual 1.3 EUR |
28/04/2019 | Annual 1.25 EUR |
29/04/2018 | Annual 1.25 EUR |
01/05/2017 | Annual 1.2 EUR |
01/05/2016 | Annual 1.05 EUR |
19/04/2015 | Annual 1 EUR |
11/05/2014 | Annual 1.9 EUR |
28/04/2013 | Annual 1.7 EUR |
22/04/2012 | Annual 1.5 EUR |
10/04/2011 | Annual 1.25 EUR |
11/04/2010 | Annual 1 EUR |
05/04/2009 | Annual 1.5 EUR |
30/03/2008 | Annual 1.2 EUR |
30/03/2008 | Bonus Payment 2 EUR |
29/04/2007 | Bonus Payment 0.15 EUR |
29/04/2007 | Annual 0.9 EUR |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 19 687 19 632 0.28% | 22 232 22 259 -0.12% | 20 993 21 026 -0.16% | 21 148 | 22 091 | 23 070 |
EBITDA Million EUR | Released Forecast Spread | 6 103 6 096 0.12% | 6 849 6 898 -0.71% | 5 879 5 823 0.97% | 6 044 | 6 558 | 6 999 |
EBIT Million EUR | Released Forecast Spread | 4 179 4 150 0.69% | 4 474 4 933 -9.29% | 3 609 3 730 -3.24% | 3 883 | 4 445 | 4 844 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 3 924 3 886 0.97% | 4 287 4 727 -9.3% | 3 484 3 695 -5.72% | 3 749 | 4 337 | 4 738 |
Net income Million EUR | Released Forecast Spread | 3 055 2 986 2.3% | 3 326 3 674 -9.48% | 2 824 2 831 -0.26% | 2 936 | 3 388 | 3 716 |
EPS EUR | Released Forecast Spread | 7,03 6,89 2.1% | 7,65 8,46 -9.54% | 6,49 6,50 -0.22% | 6,73 | 7,86 | 8,63 |
Announcement Date | 03/03/22 | 02/03/23 | 07/03/24 | - |
Quarterly results
Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 5 293 5 254 0.73% | 5 302 5 221 1.55% | 5 173 5 255 -1.56% | 5 225 5 248 -0.44% | 5 120 5 144 -0.47% | 5 352 5 248 1.98% | 5 266 5 336 -1.32% | 5 376 | 5 353 | 5 541 |
EBITDA Million EUR | Released Forecast Spread | 1 587 1 550 2.41% | 1 553 1 511 2.76% | 1 446 1 369 5.66% | 1 293 1 256 2.95% | 1 454 1 354 7.38% | 1 509 1 413 6.78% | 1 618 1 558 3.85% | 1 565 | ||
EBIT Million EUR | Released Forecast Spread | 1 035 1 124 -7.95% | 969 1 028 -5.7% | 983 903 8.89% | 621 750 -17.18% | 931 815 14.21% | 792 822 -3.64% | 1 097 1 104 -0.63% | |||
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 1 012 1 088 -7.01% | 894 981 -8.88% | 937 850 10.29% | 641 839 -23.56% | 899 785 14.55% | 785 797 -1.48% | 1 043 1 073 -2.79% | |||
Net income Million EUR | Released Forecast Spread | 796 825 -3.53% | 704 765 -8% | 739 658 12.37% | 586 647 -9.4% | 694 657 5.6% | 607 619 -1.89% | 812 830 -2.15% | 844 | ||
EPS EUR | Released Forecast Spread | 1,83 1,90 -3.6% | 1,62 1,76 -8.06% | 1,70 1,54 10.21% | 1,34 1,50 -10.42% | 1,60 1,52 5.02% | 1,40 1,41 -0.93% | 1,86 1,92 -3% | 1,94 | ||
Announcement Date | 11/05/23 | 03/08/23 | 09/11/23 | 07/03/24 | 15/05/24 | 01/08/24 | 14/11/24 | - | - | - |
Past sector events for Merck KGaA
14/11/2024 06:00 | MERCK KGAA: Q3 2024 Earnings Release |
13/11/2024 | MEZZION PHARMA CO.,LTD.: Q3 2024 Earnings Release |
12/11/2024 | OSCOTEC INC.: Q3 2024 Earnings Release |
07/11/2024 | SK BIOPHARMACEUTICALS CO., LTD.: Q3 2024 Earnings Release |
04/11/2024 | KISSEI PHARMACEUTICAL CO., LTD.: Q2 2024 Earnings Release |
04/11/2024 21:05 | SUPERNUS PHARMACEUTICALS, INC.: Q3 2024 Earnings Release |
31/10/2024 20:01 | HALOZYME THERAPEUTICS, INC.: Q3 2024 Earnings Release |
30/10/2024 | SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.: Q3 2024 Earnings Release |
30/10/2024 | KYOWA KIRIN CO. LTD.: Q3 2024 Earnings Release |
30/10/2024 | JIANGSU JIBEIER PHARMACEUTICAL CO., LTD.: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MRK Stock
- Calendar Merck KGaA
MarketScreener is also available in this country: United States.
Switch edition